Evaluation of serum cystatin C and treating efficacy of enalapril for contrast induced nephropathy after percutaneous coronary intervention / 中国基层医药

ABSTRACT

Objective To investigate the evaluation of serum cystatin C and treating efficacy of enalapril for contrast induced nephropathy after percutaneous coronary.intervention.Methods 86 patients who need coronary angiography or coronary stents implantation by skin were divided into observation group(43 cases)and control group(43 cases)randomly.The fasting venous blood was extracted and in which Cys-C and Scr were tested.All the patients were given water therapy,and enalapril was added in observation group.Diversification of concentration of Cys-C and Scr and efficacy of enalapril were recorded.Results There was no difference of Cys-C and Scr in serum and eGFR before and after operation(all P＞0.05),and the concentration of BUN was(3.96±0.89)mmol/L,which was lower after operation(P＜0.05),and the rate of CIN incidence was 2.33 ％(1 case).The concentration of Cys-C in serum was(18.4±0.58)mg/L,which was significantly higher than preoperation(P＜0.05),and there was no significant difference of Scr,eGFR and BUN before and after operation(P＞0.05),and the rate of CIN incidence was 11.63％(5 cases).Conclusion Cys-C was more sensitive in early detection for contrast induced nephropathy and more convenient.The rate of CIN incidence could be decreased by using enalapril.